$ 16.00 · 4.7 (475) · In stock
“The broader vision and mission of our study is to develop a minimally invasive blood test kit for early diagnostics, monitoring, and guiding therapeutic planning of triple-negative breast cancer patients.”
Proteomic investigation on bio-corona of Au, Ag and Fe
USA researchers identify potential biomarkers for detection and
Researchers Identify Potential Target for Rhabdomyosarcoma
Screening and predicted value of potential biomarkers for breast
Breast Cancer Research Foundation of Alabama on LinkedIn: Welcome, Kate Lloyd, to the BCRFA board of directors! ✨ Kate is a breast…
Med School Watercooler: 2023
Analysing potent biomarkers along phytochemicals for breast cancer
Advances in BRCA-associated and triple-negative breast cancer
Med School Watercooler: 2023
Frontiers Gene expression profile analysis to discover molecular
What Are the Latest Advances in Breast Cancer?
Breast Cancer Research Foundation of Alabama on LinkedIn: Welcome, Rosalind B. Griffin, to the BCRFA board of directors! ✨Rosalind…
Triple Negative Breast Cancer Market Size & Share Trends: 2032